Last reviewed · How we verify
GD-11 for injection test group — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
GD-11 for injection test group (GD-11 for injection test group) — Beijing Tiantan Hospital. GD-11 for injection is a monoclonal antibody that targets an unspecified molecular target.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GD-11 for injection test group TARGET | GD-11 for injection test group | Beijing Tiantan Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GD-11 for injection test group CI watch — RSS
- GD-11 for injection test group CI watch — Atom
- GD-11 for injection test group CI watch — JSON
- GD-11 for injection test group alone — RSS
Cite this brief
Drug Landscape (2026). GD-11 for injection test group — Competitive Intelligence Brief. https://druglandscape.com/ci/gd-11-for-injection-test-group. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab